Comparison between Crop Life Science IPO and Mono Pharmacare IPO.
Crop Life Science IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Mono Pharmacare IPO is a SME Bookbuilding proposed to list at NSE SME.
| Crop Life Science IPO | Mono Pharmacare IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Unistone Capital Pvt.Ltd. |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Nikunj Stock Brokers Ltd. | Rikhav Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Crop Life Science IPO is up to ₹25.38 Cr whereas the issue size of the Mono Pharmacare IPO is up to ₹14.07 Cr. The final issue price of Crop Life Science IPO is ₹52.00 per share and of Mono Pharmacare IPO is ₹28.00 per share.
| Crop Life Science IPO | Mono Pharmacare IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹26.00 per share | |
| Issue Price (Upper) | ₹28.00 per share | |
| Issue Price (Final) | ₹52.00 per share | ₹28.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 4000 shares |
| Fresh Issue Size | 48,80,000 shares | 50,24,000 shares |
| Fresh Issue Size (Amount) | up to ₹25.38 Cr | up to ₹14.07 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 48,80,000 shares | 50,24,000 shares |
| Issue Size Total (Amount) | up to ₹25.38 Cr | up to ₹14.07 Cr |
Crop Life Science IPO opens on Aug 18, 2023, while Mono Pharmacare IPO opens on Aug 28, 2023. The closing date of Crop Life Science IPO and Mono Pharmacare IPO is Aug 22, 2023, and Aug 30, 2023, respectively.
| Crop Life Science IPO | Mono Pharmacare IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 18, 2023 | Aug 28, 2023 |
| Issue Close | Aug 22, 2023 | Aug 30, 2023 |
| Basis Of Allotment (Tentative) | Aug 25, 2023 | Sep 04, 2023 |
| Initiation of Refunds (Tentative) | Aug 28, 2023 | Sep 05, 2023 |
| Credit of Share (Tentative) | Aug 29, 2023 | Sep 06, 2023 |
| Listing date (Tentative) | Aug 30, 2023 | Sep 07, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Crop Life Science IPO P/E ratio is 14.29, as compared to Mono Pharmacare IPO P/E ratio of .
| Crop Life Science IPO | Mono Pharmacare IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 81.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹89.13 Cr. | ₹49.47 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 11.54% | 9.01% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 18.63 | 10.34% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.68 | 2.92 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.64 | ₹1.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10.81% | 9.01% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Crop Life Science IPO Retail Individual Investors (RII) are offered 24,40,000 shares while in Mono Pharmacare IPO retail investors are offered 24,40,000 shares. Qualified Institutional Buyers (QIB) are offered in Crop Life Science IPO and 5,00,000 shares in Mono Pharmacare IPO.
| Crop Life Science IPO | Mono Pharmacare IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 2,60,000 shares | 2,76,000 shares |
| QIB | 5,00,000 shares | |
| NII | 24,40,000 shares | 22,60,000 shares |
| RII | 24,40,000 shares | 22,64,000 shares |
| Employee | ||
| Others | ||
| Total | 48,80,000 shares | 50,24,000 shares |
Crop Life Science IPO subscribed 4.36x in total, whereas Mono Pharmacare IPO subscribed 13.42x.
| Crop Life Science IPO | Mono Pharmacare IPO | |
|---|---|---|
| QIB (times) | 10.89x | |
| NII (times) | 1.56x | 8.00x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 7.15x | 19.40x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 4.36x | 13.42x |
